RS64480B1 - Postupak pripreme novih blokatora povećane vaskularne permeabilnosti u visokom prinosu - Google Patents
Postupak pripreme novih blokatora povećane vaskularne permeabilnosti u visokom prinosuInfo
- Publication number
- RS64480B1 RS64480B1 RS20230583A RSP20230583A RS64480B1 RS 64480 B1 RS64480 B1 RS 64480B1 RS 20230583 A RS20230583 A RS 20230583A RS P20230583 A RSP20230583 A RS P20230583A RS 64480 B1 RS64480 B1 RS 64480B1
- Authority
- RS
- Serbia
- Prior art keywords
- vascular leakage
- yield preparation
- novel vascular
- leakage blocker
- blocker
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/256—Polyterpene radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J17/005—Glycosides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020190166864A KR102124470B1 (ko) | 2019-12-13 | 2019-12-13 | 신규 혈관누출 차단제의 고수율 제조방법 |
| PCT/KR2020/009908 WO2021118003A1 (ko) | 2019-12-13 | 2020-07-28 | 신규 혈관누출 차단제의 고수율 제조방법 |
| EP20811233.4A EP3854800B1 (en) | 2019-12-13 | 2020-07-28 | High-yield preparation method for novel vascular leakage blocker |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS64480B1 true RS64480B1 (sr) | 2023-09-29 |
Family
ID=71142909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20230583A RS64480B1 (sr) | 2019-12-13 | 2020-07-28 | Postupak pripreme novih blokatora povećane vaskularne permeabilnosti u visokom prinosu |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11453698B2 (sr) |
| EP (1) | EP3854800B1 (sr) |
| JP (1) | JP7116384B2 (sr) |
| KR (1) | KR102124470B1 (sr) |
| CN (1) | CN113286802B (sr) |
| ES (1) | ES2954771T3 (sr) |
| HR (1) | HRP20230806T1 (sr) |
| HU (1) | HUE062421T2 (sr) |
| PL (1) | PL3854800T3 (sr) |
| RS (1) | RS64480B1 (sr) |
| WO (1) | WO2021118003A1 (sr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102124470B1 (ko) * | 2019-12-13 | 2020-06-18 | 주식회사 큐라클 | 신규 혈관누출 차단제의 고수율 제조방법 |
| EP3925966A4 (en) * | 2020-05-04 | 2022-04-06 | CURACLE Co., Ltd. | NEW CRYSTALLINE FORM OF A VASCULAR LEAK BLOCKING COMPOUND |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL102566A0 (en) | 1991-07-22 | 1993-01-14 | Harrier Inc | Glycoside compounds and production and use thereof |
| AU3068497A (en) * | 1996-05-06 | 1997-11-26 | Bionumerik Pharmaceuticals, Inc. | Process for preparing 27-hydroxy cholesterol and related derivatives |
| CN102656153B (zh) | 2009-10-29 | 2015-02-18 | 延世大学校产学协力团 | 新型血管渗漏阻断剂 |
| KR101352635B1 (ko) * | 2011-12-29 | 2014-01-20 | 연세대학교 산학협력단 | 신규 혈관누출 차단제 |
| KR101481709B1 (ko) | 2014-01-03 | 2015-02-02 | 인하대학교 산학협력단 | Ｓａｃ－１００４ 복합체를 유효성분으로 포함하는 발기부전 예방 또는 치료용 조성물 |
| WO2017010673A2 (ko) | 2015-07-16 | 2017-01-19 | 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 | 혈관누수 증후군의 예방 또는 치료용 조성물 |
| KR102124470B1 (ko) * | 2019-12-13 | 2020-06-18 | 주식회사 큐라클 | 신규 혈관누출 차단제의 고수율 제조방법 |
| KR102223276B1 (ko) * | 2020-05-04 | 2021-03-05 | 주식회사 큐라클 | 혈관 누출 차단제 화합물의 신규 결정형 |
-
2019
- 2019-12-13 KR KR1020190166864A patent/KR102124470B1/ko active IP Right Grant
-
2020
- 2020-07-28 CN CN202080003264.6A patent/CN113286802B/zh active Active
- 2020-07-28 ES ES20811233T patent/ES2954771T3/es active Active
- 2020-07-28 WO PCT/KR2020/009908 patent/WO2021118003A1/ko active Application Filing
- 2020-07-28 HU HUE20811233A patent/HUE062421T2/hu unknown
- 2020-07-28 RS RS20230583A patent/RS64480B1/sr unknown
- 2020-07-28 JP JP2020568212A patent/JP7116384B2/ja active Active
- 2020-07-28 HR HRP20230806TT patent/HRP20230806T1/hr unknown
- 2020-07-28 EP EP20811233.4A patent/EP3854800B1/en active Active
- 2020-07-28 PL PL20811233.4T patent/PL3854800T3/pl unknown
- 2020-07-28 US US17/058,518 patent/US11453698B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021118003A1 (ko) | 2021-06-17 |
| JP7116384B2 (ja) | 2022-08-10 |
| EP3854800C0 (en) | 2023-06-07 |
| CN113286802B (zh) | 2022-08-05 |
| HRP20230806T1 (hr) | 2023-11-10 |
| EP3854800A1 (en) | 2021-07-28 |
| CN113286802A (zh) | 2021-08-20 |
| ES2954771T3 (es) | 2023-11-24 |
| PL3854800T3 (pl) | 2023-11-13 |
| US20210395297A1 (en) | 2021-12-23 |
| HUE062421T2 (hu) | 2023-11-28 |
| JP2022503397A (ja) | 2022-01-12 |
| US11453698B2 (en) | 2022-09-27 |
| EP3854800B1 (en) | 2023-06-07 |
| KR102124470B1 (ko) | 2020-06-18 |
| EP3854800A4 (en) | 2021-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4029849A4 (en) | METHOD FOR PRODUCING M-TRIFLUORMETHYLPHENOL | |
| GB2589908B (en) | A method for preparing a geoolymer composition | |
| EP3805196A4 (en) | PROCESS FOR MANUFACTURING AN INDOXACARB INTERMEDIATE PRODUCT WITH HIGH OPTICAL QUALITY | |
| EP3971158A4 (en) | METHOD OF MAKING A CANNABIDIOL COMPOUND | |
| GB2598463B (en) | Improved methods for angiography | |
| EP3804853A4 (en) | PROCESS FOR MANUFACTURING S-INDOXACARB | |
| PL3854800T3 (pl) | Wysokowydajny sposób wytwarzania nowego blokera przecieku naczyniowego | |
| EP3966270A4 (en) | PROCESS FOR THE PRODUCTION OF POLYORGANOSILOXANES | |
| IL285858A (en) | A process for making levoamphetamine | |
| EP4083039A4 (en) | PROCESS FOR PREPARING ISAVUCONAZONIUM SULFATE | |
| EP3969638C0 (de) | Verfahren zum beschichten von teilen | |
| EP3950951A4 (en) | TOXIN PREPARATION METHOD | |
| GB201912863D0 (en) | Novel method | |
| EP4177250A4 (en) | PREPARATION PROCESS FOR PHENYLISOXAZOLINE COMPOUND | |
| IL282108A (en) | A method for preparing epiconazole | |
| EP3971156A4 (en) | METHOD OF FORMING A CARBON-CARBON BOND | |
| EP4059984A4 (en) | METHOD FOR PRODUCING A COMPOUND CONTAINING A FLUOROPOLYETHER GROUP | |
| SG11202111060VA (en) | Method for producing perfluoroalkyne compound | |
| PT3784036T (pt) | Método para influenciar artrópodes | |
| EP3988645A4 (en) | DECELLULARIZATION PROCESS | |
| SG11202107214UA (en) | Method for producing cyclobutane | |
| EP3603572A4 (en) | BLOOD VESSEL PROSTHESIS ENDOTHELIZATION PROCESS | |
| SG10202003538RA (en) | Method for producing highly reactive polybutene | |
| EP4019523A4 (en) | METHODS OF PRODUCTION OF L-ERYTHROBIOPTERIN COMPOUNDS | |
| EP3957641A4 (en) | METHOD FOR THE PREPARATION OF NALDEMEDINE |